Jerry S. Lanchbury - Jul 7, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Scientific Officer
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury
Stock symbol
MYGN
Transactions as of
Jul 7, 2021
Transactions value $
-$186,821
Form type
4
Date filed
7/8/2021, 05:50 PM
Previous filing
Jun 30, 2021
Next filing
Jul 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Options Exercise $806K +30.4K +13.08% $26.49 263K Jul 7, 2021 Direct F1
transaction MYGN Common Stock Sale -$982K -30.4K -11.57% $32.29 233K Jul 7, 2021 Direct F1
transaction MYGN Common Stock Options Exercise $49.9K +1.88K +0.81% $26.49 234K Jul 7, 2021 Direct F1
transaction MYGN Common Stock Sale -$60.3K -1.88K -0.8% $31.99 233K Jul 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYGN Incentive Stock Option (right to buy) Options Exercise $0 -1.88K -100% $0.00* 0 Jul 7, 2021 Common Stock 1.88K $26.49 Direct F1, F2
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -30.4K -17.66% $0.00 142K Jul 7, 2021 Common Stock 30.4K $26.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares subject to this option are fully vested and exercisable.